An unknown buyer agreed to acquire 70% stake in KPX Bio-Tech Co. Ltd. from KPX Holdings Co.,Ltd. and other shareholders for $6.1 million (KRW 6.2 billion).
June 26, 2014 at 05:00 am
Share
An unknown buyer agreed to acquire 70% stake in KPX Bio-Tech Co. Ltd. from KPX Holdings Co.,Ltd. (KOSE:A092230) and other shareholders for $6.1 million (KRW 6.2 billion) on June 3, 2014. KPX Bio-Tech had total assets of KRW 11.37 billion, total liabilities of KRW 3.68 billion and total stockholders' equity of KRW 7.69 billion as of the end of 2013. The transaction was resolved by the Board of Directors of KPX Holdings on June 3, 2014. KPMG South Korea acted as an accountant to KPX Holdings Co.,Ltd. The currency conversion has been done through www.oanda.com as on June 26, 2014.
An unknown buyer completed the acquisition of 70% stake in KPX Bio-Tech Co. Ltd. from KPX Holdings Co.,Ltd. (KOSE:A092230) and other shareholders on June 26, 2014.
KPX HOLDINGS CO., LTD. is a Korea-based company holding company engaged in the management of its subsidiaries. The Company's main subsidiaries consist of KPX CHEMICAL Co.,Ltd, engaged in the manufacture of polypropylene glycol, urethane products and electronic materials; KPX GREEN CHEMICAL CO.,LTD, mainly engaged in the provision of ethoxylates (EOA) used as surfactants; KPX Life Science Co., Ltd., engaged in the manufacture and distribution of active pharmaceutical ingredients (API) and pharmaceutical intermediates (PI), as well as KPX DEVELOPMENT CO., LTD, engaged in the management and leasing of KPX buildings and others, among others.
An unknown buyer agreed to acquire 70% stake in KPX Bio-Tech Co. Ltd. from KPX Holdings Co.,Ltd. and other shareholders for $6.1 million (KRW 6.2 billion).
KPX HOLDINGS CO., LTD. 
